05:15 PM EDT, 07/15/2025 (MT Newswires) -- Ikena Oncology ( IKNA ) said late Tuesday its shareholders have voted in favor of a merger with Inmagene Biopharmaceuticals at its annual meeting.

Upon deal closing, the combined company plans to change its name to ImageneBio from Ikena Oncology ( IKNA ) and trade on Nasdaq under the "IMA" ticker symbol.

Ikena also said it will effect a 1-for-12 reverse stock split around the end of July, prior to the closing of the merger. The reverse split will cut its shares to about 4 million from some 48.2 million.